Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombin specificity

M C Guillin1, A Bezeaud, M C Bouton

  • 1Laboratoire de Recherche sur l'Hémostase et la Thrombose, Faculté de Médecine Xavier Bichat, Paris, France.

Thrombosis and Haemostasis
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models.

Journal of thrombosis and haemostasis : JTH·2018
Same author

The future of glycoprotein VI as an antithrombotic target.

Journal of thrombosis and haemostasis : JTH·2012
Same author

[From platelet functions to therapy].

La Revue de medecine interne·2010
Same author

Functional autoantibodies against serpin E2 in rheumatoid arthritis.

Arthritis and rheumatism·2009
Same author

An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis.

Journal of thrombosis and haemostasis : JTH·2009
Same author

Monocytes downregulate the early stage of collagen-induced platelet activation by a PECAM-1-dependent mechanism.

Journal of thrombosis and haemostasis : JTH·2008
Same journal

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

Thrombosis and haemostasis·2026
Same journal

The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

Thrombosis and haemostasis·2026
Same journal

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Thrombosis and haemostasis·2026
Same journal

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Thrombosis and haemostasis·2026
Same journal

Methylglyoxal Promotes RBC-Driven Procoagulant Activity and Venous Thrombosis under Diabetes-Relevant Conditions.

Thrombosis and haemostasis·2026
Same journal

Management of Inferior Vena Cava Thrombosis: Guidance from the Italian Society for the Study of Haemostasis and Thrombosis.

Thrombosis and haemostasis·2026
See all related articles

Thrombin

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Thrombin is a key enzyme in blood coagulation.
  • Its specificity arises from interactions with active sites and exosites.
  • Understanding these interactions is crucial for drug development.

Purpose of the Study:

  • To model thrombin's interaction with various substrates and ligands.
  • To elucidate the role of exosites in thrombin's specificity.
  • To investigate conformational changes induced by ligand binding.

Main Methods:

  • Crystallographic studies of thrombin-inhibitor complexes.
  • Functional studies using mutant thrombins and antibodies.
  • Analysis of thrombin's active site and exosites.

Related Experiment Videos

Main Results:

  • A model of thrombin interaction was developed.
  • Two distinct exosites (anion binding exosite 1 and 2) were identified.
  • Exosite 1 binds fibrinogen and thrombomodulin; Exosite 2 binds heparin.
  • Ligand binding induces conformational changes affecting thrombin specificity.

Conclusions:

  • Thrombin's specificity is mediated by its active site and two exosites.
  • Exosite 1 and 2 play distinct roles in substrate/ligand recognition.
  • Further research is needed to determine exosite cooperation in fibrinogen/receptor binding.